Legislature’s impact on the outcome of infertility treatments - The German political contradiction

Pharmaceuticals Policy and Law

Volumn 9, Issue 1-2, 2007, Pages 221-227

  Thaele, Michael ^a   Uszkoreit, Monika ^b  

^a Bundesverband Reproduktionsmedizinischer Zentren Deutschlands (BRZ)   (Germany)

^b Bundesverband Reproduktionsmedizinischer Zentren Deutschlands (BRZ)   (Germany)

Author keywords

Assisted reproduction techniques; Demographic development; Economic value of children; German legislation; Health care; ICSI; IVF; Reproductive medicine

Indexed keywords

EID: 85013588337     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Deutsches IVF Register (DIR): Annual Report 2004, December 2005.
2. European population Committee of the Council of Europe: Recent demographic developments in Europe 2004 (April 2005) ISBN 10: 92-871-5665-4.
3. European Society of Human Reproduction and Embryology (ESHRE), 22nd Annual Meeting, June 18-21, 2006, Prague.
4. Gemeinsamer Bundesausschuss der Ärzte und Krankenkassen, 23.11.2004: Richtlinien über ärztliche Maßnahmen zur künstlichen Befruchtung, BAnz Nr 222, 23 190.
5. W. Ledger et al., Present Discounted Value of Children Born Using in-vitro-fertilisation (IVF) Compared to Naturally Conceived Children. A Simplified UK Calculation. Presentation, ESHRE Meeting 2006, Prague.
6. B. Lunenfeld and E. Lunenfeld, Reproductive Endocrinology: Quo Vadis? Scientific, Social, Ethical, and Economic Challenges, Gynaecol Endocrinol 12(6) (1998), 371-379.
7. Statistisches Bundesamt Deutschland, 2006.
8. World Health Organisation: Reproductive Rights, Sexual and Reproductive Health and Family Planning; International Conference on Population and Development, Cairo 1994, Chapter VII.